Patients with acute myeloid leukemia (AML) who relapse after hematopoietic stem cell
transplantation (HCT) have dismal outcomes. Our ability to predict those at risk for relapse is …

In patients receiving allogeneic stem cell transplantation (SCT) for treatment of malignant
hematologic disorders, residual leukemia can be assessed by different methodologic …

Allogeneic stem cell transplantation (allo-SCT) is the treatment of choice for many patients
with hematological malignancies, as well as some non-malignant hematological disorders …

Dear Editor, Allogeneic hematopoietic stem cell transplantation (HSCT) is an important
treatment modality for various malignant and non-malignant hematological disorders …

Background The analysis of molecular haematopoietic chimerisms (HC) has become a well-
established method to monitor the transplant evolution and to assess the risk of relapse after …

This study investigated the kinetics of CD3+-T cell chimerism (TCC) in 102 patients receiving
reduced intensity conditioning allogeneic stem cell transplantation (RIC-allo-SCT) from an …

Background Analysis of changes in recipient and donor hematopoietic cell origin is
extremely useful to monitor the effect of hematopoietic stem cell transplantation (HSCT) and …

Hematopoietic stem cell transplantation is a potentially curative therapy for a range of
malignant and non-malignant hematological diseases. Analysis of chimerism following …

The monitoring of chimerism has become a routine diagnostic instrument at centers
performing allogeneic stem cell or bone marrow transplantation. Despite the widespread …

It is recognized that chimerism following hematopoietic stem cell transplantation (HSCT) is a
dynamic process. The aims of this study were to describe the evolution of chimerism in …